American Peptide Company Announces Expansion Of New Facility

American Peptide Company, Inc. recently announced the expansion of its state-of-the-art GMP peptide manufacturing facility in Vista, California. The facility expansion will increase the company's large-scale peptide production capacity as well as enable it to continue to provide high quality peptides to its growing base of pharmaceutical and biotech customers.

This two-phase expansion encompasses the construction of peptide purification and peptide synthesis suites. Four additional purification suites will be completed in the first phase and commence operation in April 2009. This addition will include new HPLC columns and tray lyophilizers.

The second phase of the construction includes two additional large-scale synthesis suites for both solution and solid phase, and completion is forecasted for Q2 in 2009. A unique component of this expansion are the 1,000 L to 2,000 L reactors for solution phase synthesis, in addition to the 260 L to 500 L SPPS for solid phase synthesis. Storage capacity will be doubled, and a 200 L tray lyophilizer will be installed to accommodate large scale production.

"As American Peptide Company continues to grow, we are investing in our production capacity to account for a larger customer base and bulk orders," says Takahiro Ogata, president and COO, American Peptide Company. "This facility expansion is yet another initiative we have implemented to meet our customers' specific needs in the drug development and manufacturing process."

Earlier last year, American Peptide Company introduced its Total Peptide Management Program, a customized service platform designed to help pharmaceutical and life sciences industries bring new and innovative drugs to market faster. The program offers a broad portfolio of peptides, value-added services, and expert consultation to support customer needs as drug products move from discovery to development and commercialization.

About American Peptide Company, Inc.
American Peptide Company is a leading manufacturer of peptides and peptide conjugates. The company offers GMP manufacturing, custom synthesis, and pre-manufactured catalog peptides. Its manufacturing facility in Sunnyvale, California, offers research grade peptides to customers. Its Vista facility located in southern California provides GMP manufacturing and services. The company also offers a portfolio of value-added services, including process development, scale-up production, analytical and process validation, stability studies, regulatory documentation, and regulatory support.

American Peptide Company is experienced in both solid and solution phase peptide synthesis, as well as organic conjugation, proteins and PEGylation. With offices in the U.S. and presence in Japan, South Korea, and England, American Peptide Company remains dedicated to delivering high-quality peptides to pharmaceutical and biotech companies worldwide. For more information, visit www.americanpeptide.com.

SOURCE: American Peptide Company, Inc.